Genetic Associations of Parkinson's Disease Clinical, Pathological, and Data-Driven Subtypes. [PDF]
Negida A +7 more
europepmc +1 more source
Family studies in Gaucher Disease: a key resource for early diagnosis and personalized treatment strategies. [PDF]
Vinci M +12 more
europepmc +1 more source
Large-scale genetic characterization of Parkinson's disease in the African and African admixed populations. [PDF]
Akçimen F +112 more
europepmc +1 more source
Parkinson’s disease (PD) is the second most common neurodegenerative disorder and is marked by a progressive decline in motor function resulting from the loss of dopaminergic neurons in the substantia nigra pars compacta and the accumulation of α ...
Società Italiana di Biologia Sperimentale
doaj
APOE, Aβ42, and tau differentially impact cognitive decline in Sporadic, GBA1 and LRRK2 Parkinson's disease. [PDF]
Botta R +4 more
europepmc +1 more source
Protocol of ASPro-PD: a phase 3 trial of ambroxol to slow progression in genetically stratified Parkinson's disease. [PDF]
Toffoli M +18 more
europepmc +1 more source
Synuclein Disorder-Related Genetic Determinants of Mild Behavioural Impairment in a Pre-Clinical Community Cohort. [PDF]
Sander-Long M +5 more
europepmc +1 more source
Plasma Glucosylsphingosine in GBA1 E365K, N409S, and L483P Heterozygous Mutation Carriers. [PDF]
Agin-Liebes J +7 more
europepmc +1 more source
The interplay between GBA1 status and age of onset on cognitive, motor and non-motor outcomes in Parkinson's disease: multicenter cross-sectional study. [PDF]
Ledda C +19 more
europepmc +1 more source
Clinical and Biological Determinants of Longitudinal Cognitive Function in Patients With GBA1 Variants and Subthalamic Deep Brain Stimulation. [PDF]
Loeffler MA +8 more
europepmc +1 more source

